Exact(4)
However, with our approach, likely responder cases can be chosen before therapy.
Baseline characteristics and illness severity for likely responder, likely non-responder, and not predictable groups are shown in Table 5.
Mean improvement from baseline to Week 8 in QLS Total scores was 13.8, 7.1, and 3.7 points for the likely responder, not predictable, and likely non-responder groups, respectively (p <.001).
Baseline characteristics of likely responder, likely non-responder, and not predictable groups were compared using analysis of variance (ANOVA) and the Cochran-Mantel-Haenszel test accounting for study effect.
Similar(56)
The decision tree applied to the learning data set is illustrated in Figure 2. Of the 1494 patients in the learning data set, 644 (43%) ultimately demonstrated response, defined as a ≥30% improvement in PANSS Total score at Week 8. Using the first branch criterion, 445 patients were identified as likely responders, of which 352 actually responded (PPV = 79%).
Attempts to identify likely responders have been made in the neoadjuvant setting, with pre- and post-treatment biopsies being used to study biomarker changes.
The role of medical imaging in pharmaceutical clinical trials includes identification of likely responders; detection and diagnosis of lesions and evaluation of their severity; and therapy monitoring and follow-up.
It is in this latter group of non-del 5q) non-del 5q a strategy for potentially preselecases likely responders is suggesthatby the finding of an exprestrategyofore associated with respotentially
For the two hypomethylating agents, response remains limited to 50% patients at best, and no strategy has evolved to allow for pre-selection of likely responders, however, 5-azacytidine has been associated with improvement in the survival of higher risk patients.
Similar studies may be important in identifying likely responders for common smoking cessation treatments.
In analyses of the 3 predicted response groups, patients identified as likely responders were more commonly female and had a shorter duration of illness than likely non-responders.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com